rxstatShortages › Tranexamic Acid

Tranexamic Acid (Cyklokapron) shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Jul 22, 2026

Some Tranexamic Acid products are in shortage in Canada (5 of 11 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Nov 13, 2026.

A medication used to reduce heavy bleeding, such as heavy menstrual periods or bleeding after surgery.

Products affected
5 / 11
In shortage since
Apr 25, 2018
Est. full return
Nov 13, 2026
Reports on file
54
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Book a pharmacist appointment
Need your prescription switched?
If your product stays unavailable, an online doctor can assess your situation and prescribe an alternative.
See a doctor online

Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.

Shortage history

2023 2024 2025 2026

Shortage history (red bands = periods in shortage).

Reports by product

The DIN is printed on your prescription label.

Active shortage
TRANEXAMIC ACID INJECTION
100MG · SOLUTION · OMEGA LABORATORIES LIMITED
DIN 02392763 · since Jul 20, 2026, est. end Sep 30, 2026 · Demand increase for the drug.
Active shortage
TRANEXAMIC ACID INJECTION BP
100MG · SOLUTION · SANDOZ CANADA INCORPORATED
DIN 02246365 · since Jun 8, 2026, est. end Sep 4, 2026 · Requirements related to complying with good manufacturing practices.
Active shortage
TRANEXAMIC ACID INJECTION
100MG · SOLUTION · JAMP PHARMA CORPORATION
DIN 02497328 · since Jun 30, 2026, est. end Nov 13, 2026 · Disruption of the manufacture of the drug.
Active shortage
ERFA-TRANEXAMIC
100 mg/mL · Solution · SEARCHLIGHT PHARMA INC
DIN 02457431 · since Apr 25, 2018, no end estimate · 5ML - estimated end date is unknown 10ml - estimated end date is unknown 20x5ml - estimated end date is unknown
Active shortage
TRANEXAMIC ACID INJECTION BP
100MG · SOLUTION · STERIMAX INC
DIN 02386933 · since Oct 28, 2020, no end estimate · Demand increase for the drug.
Active shortage
TRANEXAMIC ACID INJECTION BP
100MG · SOLUTION · STERIMAX INC
DIN 02386933 · since Jul 1, 2020, no end estimate · Demand increase for the drug.
Active shortage
TRANEXAMIC ACID INJECTION BP
100MG · SOLUTION · STERIMAX INC
DIN 02386933 · since Apr 20, 2020, no end estimate · Demand increase for the drug.
Anticipated
TRANEXAMIC ACID INJECTION
100MG · SOLUTION · OMEGA LABORATORIES LIMITED
DIN 02392763 · Demand increase for the drug.
Anticipated
TRANEXAMIC ACID TABLETS
500MG · TABLET · STERIMAX INC
DIN 02401231 · Delay in shipping of the drug.
Resolved
TRANEXAMIC ACID INJECTION
100MG · SOLUTION · OMEGA LABORATORIES LIMITED
DIN 02392763 · ended Jun 19, 2026 · Disruption of the manufacture of the drug.
Resolved
TRANEXAMIC ACID INJECTION
100MG · SOLUTION · OMEGA LABORATORIES LIMITED
DIN 02392763 · ended Jun 18, 2026 · Disruption of the manufacture of the drug.
Resolved
TRANEXAMIC ACID INJECTION
100MG · SOLUTION · OMEGA LABORATORIES LIMITED
DIN 02392763 · ended May 28, 2026 · Disruption of the manufacture of the drug.

Showing 12 of 54 reports. All reports are on file with Health Canada.

What's happening

Tranexamic Acid is currently affected by 5 active shortage reports filed with Health Canada by OMEGA LABORATORIES LIMITED, SANDOZ CANADA INCORPORATED, JAMP PHARMA CORPORATION, SEARCHLIGHT PHARMA INC and 1 others.

The reported causes are: demand increase for the drug; requirements related to complying with good manufacturing practices; disruption of the manufacture of the drug; 5ml - estimated end date is unknown 10ml - estimated end date is unknown 20x5ml - estimated end date is unknown. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Tranexamic Acid is classified under “ANTIFIBRINOLYTICS” (ATC B02AA).

Recent changes

Common questions

What is Tranexamic Acid used for?

A medication used to reduce heavy bleeding, such as heavy menstrual periods or bleeding after surgery.

When will Tranexamic Acid be back in stock in Canada?

The latest manufacturer estimate is Nov 13, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.

Why is Tranexamic Acid in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Possible alternatives in the same class (antifibrinolytics)

Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.